Tolerance to endotoxins that is triggered by prior exposure to Toll-like receptor (TLR) ligands provides a mechanism with which to dampen inflammatory cytokines. The receptor-interacting protein RIP140 interacts with the transcription factor NF-kB to regulate the expression of genes encoding proinflammatory cytokines. Here we found lipopolysaccharide stimulation of kinase Syk-mediated tyrosine phosphorylation of RIP140 and interaction of the NF-kB subunit RelA with RIP140. These events resulted in more recruitment of the E3 ligase SCF to tyrosine-phosphorylated RIP140, which degraded RIP140 to inactivate genes encoding inflammatory cytokines. Macrophages expressing nondegradable RIP140 were resistant to the establishment of endotoxin tolerance for specific 'tolerizable' genes. Our results identify RelA as an adaptor with which SCF fine tunes NF-kB target genes by targeting the coactivator RIP140 and show an unexpected role for RIP140 degradation in resolving inflammation and endotoxin tolerance.
Pattern-recognition receptors, including Toll-like receptors (TLRs), are responsible for sensing microbial infection and tissue damage and for initiating innate immune responses. After exposure of cells to TLR ligands, TLRs trigger inflammatory signaling to activate pathways of the transcription factor NF-κB and mitogen-activated protein kinases (MAPKs) and to promote the production of proinflammatory cytokines such as tumor-necrosis factor (TNF) and interleukin 1β (IL-1β) 1, 2 . These proinflammatory cytokines not only induce inflammation but also modulate the adaptive immune response. Chronic inflammation and aberrant production of proinflammatory cytokines are critical in many diseases, especially metabolic diseases such as type 2 diabetes mellitus and atherosclerosis [3] [4] [5] . Therefore, tight control of the production of proinflammatory cytokines and resolution of inflammation after infection and/or tissue damage are important for maintaining tissue homeostasis. Diminished proinflammatory signaling, nonpermissive histone modifications, chromatin remodeling and microRNA production induced by inflammatory stimuli all resolve inflammation by impairing the production of proinflammatory cytokines by inhibiting the activity of NF-κB and MAPKs 2,6-9 .
Tolerance to endotoxins provides a protective mechanism with which to diminish the overproduction of proinflammatory cytokines in response to infection. Defects in the establishment of endotoxin tolerance lead to a higher incidence of septic shock and mortality in infected people. However, people with endotoxin tolerance become immunocompromised 10, 11 . Therefore, understanding the mechanisms that control endotoxin tolerance is important to the design of interventions to fine tune immune responses. In addition to monocytes, macrophages are the main cell type involved in endotoxin tolerance in animals, and the TLR4 ligand lipopolysaccharide (LPS) is most commonly used to induce endotoxin tolerance in vivo and in vitro 9, 12 . Although suppression of TLR-mediated inflammatory signaling pathways by negative regulators has been proposed as a mechanism for the establishment of endotoxin tolerance, this mechanism cannot fully explain why and how certain genes are efficiently silenced but other genes that use the same signaling pathways can still be activated in LPS-tolerant macrophages 8 . Many studies have demonstrated that changes in chromatin, including loss of binding of the NF-κB subunit RelA, histone modification and chromatin remodeling, provide the main regulatory mechanisms for the suppression of specific genes in endotoxin tolerance 8, 9, 12, 13 . However, how such changes in specific chromatin targets are controlled is largely unclear.
The receptor-interacting protein RIP140 can act as corepressor or coactivator of various transcriptional factors and nuclear receptors, and it is expressed mainly in metabolic organs and tissues, including adipose tissue, liver and muscle [14] [15] [16] . RIP140-null mice resist dietinduced type 2 diabetes mellitus, and RIP140 regulates the metabolism of lipid and glucose in metabolic tissues through its nuclear and cytoplasmic functions 15, [17] [18] [19] [20] [21] . Proteomic analyses have identified various post-translational modifications of RIP140 that modulate its function and subcellular distribution, such as phosphorylation of serine and threonine, lysine acetylation, sumoylation, and methylation of lysine and arginine [22] [23] [24] [25] . However, tyrosine phosphorylation has not been detected on RIP140 so far. RIP140 functions in macrophages as a coactivator for NF-κB by recruiting the coactivator CBP to modulate the production of proinflammatory cytokines such as TNF, IL-1β and IL-6 induced by TLRs (at least, by TLR2, TLR3 3 8 0 VOLUME 13 NUMBER 4 APRIL 2012 nature immunology A r t i c l e s and TLR4) 26 . Additionally, modulation of RIP140 expression by the microRNA miR-33 affects the inflammatory potential of macrophages in response to intracellular cholesterol concentrations 27 . Such studies indicate a role for RIP140 in the production of proinflammatory cytokines and suggest that it is important to regulate RIP140 expression to modulate the inflammatory potential of macrophages.
Ubiquitin contains five lysine residues (Lys6, Lys11, Lys29, Lys48 and Lys63) that are involved in monoubiquitination and polyubiquitination. Specifically, Lys48 (K48)-linked ubiquitination targets proteins to proteasome-mediated degradation 28 . Ubiquitination and proteasome-mediated protein degradation are involved in both positive and negative regulation of TLR signal transduction. In this context, degradation of the inhibitor IκB is best characterized; IκB controls NF-κB activity by regulating the subcellular localization of NF-κB 1,2 . Additionally, E3 ligase complex containing the signaling inhibitor SOCS1 and the ligase Rbx1 is known to interact with RelA and promote RelA degradation in nuclei 29, 30 . However, how the regulation of specific chromatin targets to negatively regulate the inflammatory response is achieved remains largely unknown.
We report here that degradation of RIP140, triggered by exposure of macrophages to TLR ligands, represents another mechanism for the negative regulation of specific genomic targets in the inflammatory response to promote endotoxin tolerance. LPS stimulated the interaction of RIP140 with RelA, which led to recruitment of the E3 ligase SCF. In addition, LPS activated phosphorylation of RIP140 on Tyr364, Tyr418 and Tyr436 mediated by the kinase Syk, facilitating its ubiquitination. Together these triggered efficient degradation of RIP140 to dampen inflammation and induce endotoxin tolerance. Prevention of RIP140 degradation by pretreatment of macrophages with interferon-γ (IFN-γ) or overexpression of nondegradable RIP140 effectively diminished LPS-induced endotoxin tolerance in vitro and in vivo. Our results not only identify a previously unknown regulatory mechanism by which RIP140 regulates the inflammatory response but also show that RelA acts as an adaptor for an E3 ligase to dynamically control RelA's specific coactivator to fine tune transcriptional activity for specific chromatin targets.
RESULTS

Less RIP140 in macrophages treated with TLR ligands
To determine whether RIP140 expression can be modulated by exposure to LPS in the establishment of endotoxin tolerance, we preinjected mice with saline (control vehicle) or a low dose of LPS, challenged the mice 16 h later with a lethal dose of LPS plus d-galactosamine and then monitored their survival ( Supplementary  Fig. 1 ). As expected, exposure to a low dose of LPS before the lethal dose of LPS resulted in much better survival 31 (Fig. 1a) . We monitored the expression of RIP140 in F4/80 + peritoneal macrophages and found ~40% less RIP140 protein in LPS-tolerant mice than in salinetreated mice (Fig. 1b) . We reasoned that because RIP140 modulates the production of proinflammatory cytokines by acting as an NF-κB coactivator 26, 27 , downregulation of RIP140 in macrophages might dampen inflammatory responses and improve survival during acute sepsis. To test our theory, we generated a transgenic mouse model with macrophage-specific silencing of the gene encoding RIP140, as whole-body deletion of RIP140 in mice results in altered lipid and glucose metabolism, which would affect survival of such a mouse line in a model of septic shock. We used the promoter of the human gene CD68 for macrophage-specific expression of RIP140-specific short hairpin RNA 32 (Supplementary Fig. 2a ). Macrophages from mice with macrophage-specific knockdown of RIP140 had ~80% lower expression of RIP140 mRNA (Supplementary Fig. 2b ). As expected, these mice had improved survival ( Fig. 1c ) and lower circulating concentrations of TNF and IL-1β ( Fig. 1d ) than wild-type mice had. These results showed that downregulation of RIP140 in macrophages could be protective against septic shock.
Macrophage polarization, including classical (M1) and alternative (M2) activation, has a critical role in various diseases 33, 34 . As LPS is a stimulus for M1 activation, we sought to determine whether RIP140 was affected differently in M1 activation versus M2 activation in macrophages. In agreement with the in vivo data, the M1 stimulus (IFN-γ plus LPS) resulted in less RIP140 protein in both primary mouse macrophages ( Fig. 1e ) and RAW264.7 (RAW) mouse macrophages ( Supplementary Fig. 3 ) without substantially affecting the amount of RIP140 mRNA, but the M2 stimulus (IL-4) did not. Furthermore, exposure to LPS decreased RIP140 protein in a dose-and timedependent manner ( Supplementary Fig. 4 ). To distinguish among the various TLRs and adaptor signaling pathways, we examined the effects of the TLR2 ligand Pam 3 CSK 4 and the TLR3 ligand poly (I:C) on RIP140 protein. Treatment with stimuli for TLR2, TLR3 or TLR4 all resulted in less RIP140 (Fig. 1f ). Together these results showed that RIP140 protein was downregulated in macrophages after exposure to npg ligands for TLR2, TLR3 or TLR4 and suggested that less RIP140 may provide a regulatory mechanism for diminishing the inflammatory response and the establishment of endotoxin tolerance.
LPS triggers RIP140 degradation by an SCF E3 ligase complex
To determine whether protein degradation contributed to the LPStriggered decrease in RIP140 protein, we treated RAW cells with LPS in the presence or absence of the proteasome inhibitor MG132. Treatment with MG132 resulted in more ubiquitination of RIP140 during LPS treatment ( Fig. 2a) , which suggested that proteasomemediated degradation of ubiquitinated RIP140 contributed to the LPStriggered decrease in RIP140 protein in LPS-tolerant macrophages. LPS also promoted RIP140 degradation in a pulse-chase experiment ( Supplementary Fig. 5 ). In a bacterial two-hybrid screening, we identified Rbx1 as an RIP140-interacting protein (data not shown). Because Rbx1 is a component of the SCF E3 ligase complex that transfers the polyubiquitin chain to lysine residues of target proteins 29 , we next determined whether Rbx1 contributed to the LPS-triggered ubiquitination of RIP140. Indeed, knockdown of Rbx1 blocked the LPS-induced degradation of RIP140 in both primary macrophages ( Fig. 2b) and RAW cells ( Supplementary Fig. 6a ). SOCS1, another component of the SCF E3 ligase, can associate with Rbx1, and SOCS1 is responsible for target recognition; SOCS1 also negatively regulates inflammation and contributes to the establishment of endotoxin tolerance [35] [36] [37] . We therefore determined whether SOCS1 was involved in the LPS-triggered degradation of RIP140. As expected, LPS induced the expression of SOCS1 protein, and knockdown of SOCS1 also resulted in less LPS-triggered degradation of RIP140 in primary macrophages ( Fig. 2c ) and RAW cells ( Supplementary Fig. 6b ). To determine if RIP140 was a direct target of the SOCS1-Rbx1 E3 ligase, we did an in vivo ubiquitination assay in 293T human embryonic kidney cells by ectopically coexpressing Flag-tagged RIP140 and hemagglutinin-tagged Rbx1 or SOCS1 in the presence of wild-type or mutant ubiquitin. Both SOCS1 and Rbx1 promoted RIP140 ubiquitination in the presence of wild-type ubiquitin but not in the presence of mutant ubiquitin with substitution of arginine for the lysine at position 48 (Fig. 2d,e) . These experiments also confirmed that RIP140 was able to associate with Rbx1 and SOCS1. Because SOCS1 recognizes tyrosine-phosphorylated substrates through its Src homology 2 (SH2) domain 29, 30, 37 , we then determined whether the SH2 domain of SOCS1 was required for RIP140 degradation through the use of an SH2-mutant SOCS1 that failed to recognize its specific targets. Wild-type SOCS1 effectively stimulated RIP140 ubiquitination, but the SH2-mutant SOCS1 did not ( Fig. 2f) . These results demonstrated that LPS triggered RIP140 degradation by promoting ubiquitination of RIP140 mediated by the SOCS1-Rbx1 E3 ligase.
RelA is an adaptor for SOCS1-RIP140 association Although we found that SOCS1-Rbx1 associated with RIP140 in vivo, we did not detect direct interaction of RIP140 with SOCS1 in vitro (data not shown). As RelA is a target for the nuclear SOCS1-Rbx1 E3 ligase and RIP140 interacts with RelA to coactivate the transcriptional activity of RelA 26, 29, 30 , we next sought to determine whether RIP140 associates with SOCS1 in a RelA-dependent manner in coimmunoprecipitation assays. We found that in 293T cells with ectopic expression of Flagtagged RIP140 with or without hemagglutinin-tagged SOCS1, RIP140 did not associate with SOCS1 in cells in which RelA was knocked down ( Fig. 3a) . Furthermore, RIP140 was no longer degraded after knockdown of RelA in primary macrophages ( Fig. 3b ) or RAW cells ( Supplementary Fig. 6c ), with LPS stimulation. These results suggested that the association of RIP140 with RelA provided a regulatory step for the recruitment of SOCS1 to RIP140. Because RelA interacts with the amino terminus of RIP140 (ref. 26) , we assessed whether overexpression of a Flag-tagged amino terminus of RIP140 would result in less association of RIP140 with RelA and LPS-triggered degradation of RIP140. Indeed, that overexpression resulted in less LPS-triggered association of RIP140 with RelA in RAW cells, downregulated the expression of target genes (such as those encoding TNF and IL-1β; Fig. 3c ) and dampened LPS-triggered degradation of RIP140 ( Fig. 3d ). Together these results showed that RelA acted as an adaptor for the SOCS1-Rbx1 E3 ligase to control the degradation of RIP140. In addition to ligands for TLRs, TNF can also activate a signaling cascade to promote NF-κB-mediated production of proinflammatory cytokines 3, 12 , but it promotes endotoxin tolerance through mechanisms distinct from those of LPS-induced endotoxin tolerance 12 . TNF did not enhance formation of the RIP140-RelA complex above the basal amount ( Fig. 3e) and, more notably, after 24 h of treatment, TNF still did not result in less RIP140 protein in primary macrophages ( Fig. 3f ) or RAW cells (Supplementary Fig. 7) . These results further supported our hypothesis that LPS-stimulated interaction of RIP140 with RelA results in recruitment of the SOCS1-Rbx1 E3 ligase in a TLR-specific manner, which is required for the degradation of RIP140. A r t i c l e s RIP140 degradation requires phosphorylation of RIP140 Tyrosine phosphorylation has a critical role in regulating proteasomemediated protein degradation via various mechanisms 7, 28 . Analysis of LPS-induced tyrosine phosphorylation of RIP140 showed that RIP140 was phosphorylated within 1 h of LPS challenge, immediately before we were able to detect RIP140 degradation ( Fig. 4a and Supplementary Fig. 4b ). Syk, a nonreceptor tyrosine kinase, showed similar activation kinetics after LPS challenge ( Fig. 4b) . Syk also has an important role in resolving inflammation, and Syk-null mice are susceptible to LPS-induced sepsis 38, 39 . We found that treating LPSexposed RAW cells with a Syk inhibitor helped to sustain their abundance of RIP140 protein (Fig. 4c) , and knocking down Syk prevented LPS-triggered RIP140 degradation in both primary macrophages and RAW cells ( Fig. 4d) . Additionally, we found accumulation of Syk in the nuclei with LPS treatment (Supplementary Fig. 8a) . In a proximalligation assay, we detected more interaction of RIP140 with Syk in the nuclei of LPS-challenged RAW macrophages than in naive RAW macrophages ( Supplementary Fig. 8b) . These results suggested that Syk may phosphorylate RIP140 to regulate the stability of RIP140.
An in vitro kinase assay showed that Syk phosphorylated RIP140 on its tyrosine residues, and this was blocked by the Syk inhibitor ( Fig. 4e) . With a group-based prediction system, we identified three highly conserved tyrosine residues (Tyr364, Tyr418 and Tyr436) on RIP140, which were predicted to be targets of Syk (Fig. 5a ). By the same in vitro kinase assay, we demonstrated that substitution of all three of those tyrosine residues with phenylalanine (Y3F) effectively blocked Syk-mediated tyrosine phosphorylation of RIP140 (Fig. 5b) . Mutant RIP140 with the Y3F substitution showed much less tyrosine phosphorylation ( Fig. 5c and Supplementary Fig. 9 ). In addition, both wild-type RIP140 and the Y3F-mutant RIP140 interacted with Syk in primary macrophages after LPS challenge (Fig. 5d) . However, the Y3F-mutant RIP140 became resistant to degradation in macrophages after LPS challenge (Fig. 5e) . Although the Y3F-mutant RIP140 showed greater stability, it was possible that these substitutions abolished the interaction of RIP140 with RelA, thereby diminishing the association of RIP140 with the SOCS1-Rbx1 E3 ligase. It seemed that the Y3F mutant was still able to interact with RelA under basal conditions, and this interaction was also enhanced by LPS Figure 4 Syk activity is required for LPS-induced degradation of RIP140. (a) Immunoassay of lysates of RAW macrophages transfected with plasmid for Flag-tagged wild-type RIP140 and then treated for 0, 1, 2 or 4 h with LPS (10 ng/ml) in the presence of MG132, followed by immunoprecipitation with agarose conjugated to antibody to phosphorylated tyrosine (IP: p-Tyr) and immunoblot analysis with anti-Flag (to detect phosphorylated RIP140). Input, immunoblot analysis of 10% of the lysate without immunoprecipitation. (b) Immunoblot analysis of total or phosphorylated (p-) Syk or total RIP140 in lysates of RAW macrophages treated for 0, 1, 2 or 4 h with LPS (10 ng/ml). npg treatment (Supplementary Fig. 10 ). Furthermore, this Y3F mutant remained associated with SOCS1 ( Supplementary Fig. 11a) . In vitrophosphorylated wild-type Flag-tagged RIP140 did not associate with SOCS1 in a direct protein-interaction assay ( Supplementary  Fig. 11b ). These data supported our conclusion that RelA acted as an adaptor to facilitate the association of RIP140 with SOCS1 and confirmed the idea that Syk-mediated phosphorylation at three conserved tyrosine residues of RIP140 was critical for conjugation of the polyubiquitin chain on RIP140; however, this was not required for SOCS1 to recognize RIP140 or for the interaction of RIP140 with RelA.
Abrogation of RIP140 degradation prevents endotoxin tolerance
Exposure to LPS induced RIP140 degradation and less production of inflammatory cytokines in macrophages, which suggested that degradation of RIP140 may resolve inflammation and promote the establishment of endotoxin tolerance. IFN-γ activates macrophages to amplify the inflammatory response, and one of its important functions is to diminish endotoxin tolerance and restore the production of proinflammatory cytokines 9, 40 . Pretreatment of macrophage with IFN-γ has been shown to overcome LPS-induced endotoxin tolerance 9 . Therefore, we sought to determine whether pretreatment with IFN-γ blocked the degradation of RIP140 and if RIP140 was required for IFN-γ-restored production of inflammatory cytokines, especially TNF and IL-1β, in LPS-tolerant macrophages. Indeed, pretreatment with IFN-γ effectively suppressed LPS-triggered degradation of RIP140 in primary macrophages ( Fig. 6a ) and RAW macrophages ( Supplementary Fig. 12) , and IFN-γ did not restore the production of TNF and IL-1β when RIP140 was knocked down ( Supplementary  Fig. 13 ). We also confirmed the requirement for RIP140 in the effect of IFN-γ on preventing endotoxin tolerance in experiments with primary peritoneal macrophages from wild-type mice or mice with macrophage-specific knockdown of RIP140 ( Supplementary  Fig. 14) . IFN-γ effectively prevented endotoxin tolerance in macrophages from wild-type mice but not in those from mice in which RIP140 was knocked down (Fig. 6b) . To further investigate the role of RIP140 degradation in the establishment of endotoxin tolerance, we introduced a control vector or vector for the expression of wild-type or Y3F-mutant RIP140 into RAW cells, induced tolerance with LPS and then monitored the production of proinflammatory cytokines after a second LPS stimulation. Cells given the vector for Y3F-mutant RIP140 were resistant to tolerance induction with LPS, but those given control vector or the vector for wild-type RIP140 were not, on the basis of criteria such as expression of TNF mRNA and production of TNF protein after the second LPS challenge (Fig. 6c ). P  K  K  N  N  NN  NCVPI  T  T TTID  D  DE  S  S  S  S  SS  SS S  G  LE  E  R  Y  SSPK  K  N  N  TS  SLER  Y  SSPK  K  N  N  AG  SLER  Y   Y  Y  NCVPI  DE  SS  SS S  G  Y  NCVPI  DE  SS  SS S  G  Y  NCVPI  DE  SS  SS S  G  Y  NCVPI  DE  SS  SS S  G  Y  NCVPI  DE  SS  SS S  G  Y   P  P  NN  T TTID  D  S  S  EY  P  P  NN  T TTID  D  S  S  EY  P  P  NN  T TTID  D  S  S  EY  P  P  NN  T TTID  D  S  S  EY  P  P  NN  T TTID  D  S  S  EY   SSPK  K  N  N  AG  SLER  Y  SSPK  K  N  N  AG  SLER  Y  SSPK  K  N  N  AG The effect on IL-1β mRNA expression was in agreement with those results (Supplementary Fig. 15 ). As altered signaling cascades in LPS-stimulated activation of the kinase IKK and MAPKs are also important characteristics of endotoxin tolerance, we thus investigated whether the Y3F-mutant RIP140 prevented endotoxin tolerance by augmenting such signaling pathways. This proved not to be the case because we did not observe any substantial difference in these signaling cascades in RAW cells transfected to express wild-type or Y3F-mutant RIP140 relative to the cascades in cells transfected with control vector (Supplementary Fig. 16) . These results showed that expressing the nondegradable Y3F-mutant RIP140 attenuated endotoxin tolerance, which occurred in a manner independent of signaling via MAPKs and IKK. To further confirm the effect of expressing the nondegradable Y3Fmutant RIP140 on endotoxin tolerance in vivo, we introduced wildtype or Y3F-mutant RIP140 into primary macrophages by lentiviral infection, then challenged the cells for 24 h with LPS. We then collected the macrophages and injected them into mice that had been depleted of macrophages to achieve macrophage reconstitution ( Supplementary  Fig. 17) . After macrophage reconstitution, we challenged mice for 1 h with LPS and measured serum TNF by enzyme-linked immunosorbent assay. As expected, mice reconstituted with macrophages expressing wild-type RIP140 failed to promote TNF production. However, mice reconstituted with macrophages expressing Y3F-mutant RIP140 produced more serum TNF in response to the second LPS challenge (Fig. 6d) . Overall, our results demonstrated that RIP140 degradation was essential for the establishment of endotoxin tolerance, at least on the basis of the criterion of the production of TNF and IL-1β. Moreover, prevention of RIP140 degradation, such as that achieved by pretreatment with IFN-γ, attenuated endotoxin tolerance.
SSP P
Nondegradable RIP140 increases 'tolerizable gene' expression
Analysis of gene expression by LPS-tolerant or nontolerant macrophages has demonstrated that TLRs induce histone modifications and chromatin remodeling in a gene-specific manner 8, 41 . Microarray analysis has shown that most genes with different expression in RIP140-null macrophages versus wild-type macrophages are genes encoding proinflammatory molecules 26 . We therefore compared the genes with different expression in RIP140-null macrophages to a list of genes categorized before as not induced during primary stimulation ('tolerizable genes') or still inducible in tolerant macrophages ('nontolerizable genes') 8, 26 and found that nine of the 'tolerizable' genes but only one of the 'nontolerizable' genes were targets of RIP140 (Supplementary Fig. 18 ). We examined whether overexpression of the nondegradable Y3F-mutant RIP140 in macrophages increased the expression of target genes of RIP140 in conditions of endotoxin tolerance. Ectopic expression of Y3F-mutant RIP140 resulted in higher expression of target genes of RIP140 (including Ptgs2, Traf1, Socs3 and Il6, in addition to Tnf and Il1b), but expression of the control vector or wild-type RIP140 did not. However, the Y3F-mutant RIP140 did not affect the expression of genes that are not the targets of RIP140 (such as Ccl22, Cd40 and Nos2) in either primary macrophages (Fig. 7a) or RAW cells (Supplementary Fig. 19) . These results showed that RIP140 degradation contributed to the establishment of endotoxin tolerance in a gene-specific way. npg A r t i c l e s Most 'tolerizable' genes, such as those encoding TNF and IL-1β, are characterized by their nonpermissive histone modifications and less binding of NF-κB to their promoters during LPS challenge 8, 9, 12, 13, 41, 42 . However, the underlying mechanism for those characteristics has remained unclear. Thus, we sought to determine whether degradation of RIP140 was involved in changing those specific chromatin targets by expressing control vector, wild-type RIP140 or Y3F-mutant RIP140 in RAW cells and inducing tolerance by LPS challenge. After stimulating the macrophages with a second dose of LPS, we monitored the binding of RelA and RIP140 to the promoters of Tnf, Il1b, Ccl5 and Nos2 by chromatin immunoprecipitation. In response to treatment with LPS, the binding of RIP140 to its targets (Tnf and Il1b) was enhanced, but this did not happen on the genes that are not RIP140 targets (Ccl5 and Nos2). The binding of RelA to the promoters of Tnf and Il1b was also greater in macrophages transfected to express Y3Fmutant RIP140 but not in cells of the other groups (Fig. 7b) . We also monitored activating histone modifications, including acetylation of histone H4 or histone H3 and phosphorylation of Ser10 of histone H3 in the RelA-binding regions of the promoters of Tnf and Il1b. In addition to the phosphorylation of Ser10 on histone H3, acetylation of H3 and H4 was also greater in macrophages transfected to express Y3F-mutant RIP140 but not in the other groups, in the tolerant state ( Fig. 7c) . Together these results supported the view that LPSstimulated degradation of RIP140 contributed to the loss of RelA binding and active histone modifications on the promoters of genes encoding proinflammatory cytokines in LPS-tolerant macrophages. Moreover, we demonstrated that Syk-mediated tyrosine phosphorylation and RelA-dependent recruitment of the SOCS1-Rbx1 E3 ligase were two prerequisites for LPS-triggered degradation of RIP140 (Supplementray Fig. 20) .
DISCUSSION
RIP140 promotes the production of proinflammatory cytokines by serving as a coactivator for NF-κB in macrophages exposed to TLR ligands. In this study, we found that exposure to TLR ligands triggered degradation of RIP140, which led to resolution of the inflammatory response and contributed to endotoxin tolerance in a gene-specific manner. Syk-mediated tyrosine phosphorylation and RelA-dependent recruitment of the E3 ligase were two prerequisites for LPS-triggered degradation of RIP140. To our knowledge, this unexpected finding is the first example of negative regulation of a TLR-mediated inflammatory response through targeting of a specific NF-κB coactivator. We also found that NF-κB, specifically its RelA subunit, modulated its own transcriptional activity by recruiting the SCF E3 ligase complex to target the RelA-associated coactivator.
Most studies of negative regulation of inflammation have focused on TLR-mediated signal transduction and have suggested that such regulation is involved in the establishment of endotoxin tolerance 10, 11, 41 . However, alterations of chromatin, including histone modifications and chromatin remodeling, have been shown to render complete and genespecific tolerance with a diminished signaling cascade 2, 41, 42 . Although several potential negative regulatory mechanisms in the nucleus have been proposed, the link between those mechanisms and the specific changes on chromatin targets under endotoxin tolerance induction have remained unclear. Among those nuclear regulatory events, it has been shown that SOCS1-Rbx1, an SCF E3 ligase, can degrade RelA to terminate the transcriptional activity of NF-κB 29, 30, 43 and that SOCS1 recognizes its substrate via its SH2 domain, which interacts with phosphorylated tyrosine residues on the substrate protein 37 . We found Syk phosphorylated RIP140 on three tyrosine residues, but we did not detect direct interaction of RIP140 with SOCS1, even for RIP140 that had been phosphorylated by Syk. We did confirm that the SH2 domain of SOCS1 was essential for the ubiquitination of RIP140. As the association of RelA with the SOCS1-Rbx1 E3 ligase requires the SOCS1 SH2 domain 29, 43 and RelA directly interacts with RIP140, we conclude that RelA acts as an adaptor for the SOCS1-Rbx1 E3 ligase to recruit RIP140 into the E3 complex. Consistent with that, SOCS1deficient mice have a higher inflammatory response and lower survival during septic shock, and SOCS1-deficient macrophages show less endotoxin tolerance 35, 36 , which also supports our findings that SOCS1-mediated degradation of RIP140 resolved inflammation and promoted the establishment of endotoxin tolerance. We have also identified a previously unrecognized mechanism exerted by RelA itself to downregulate its coactivator. This is the first example, to our knowledge, of regulation of a coactivator's stability by an SCF E3 ligase via interaction with RelA.
Syk-null mice also have lower survival and more severe inflammatory responses during LPS challenge relative to those of wildtype mice, which suggests that Syk is involved in the resolution of inflammation 38 . It has been reported that CD11b diminishes the TLR-triggered inflammatory response via Syk-mediated phosphorylation of the adaptors MyD88 and TRIF 39 . Our results presented here further support the proposal of a role for Syk in negative regulation of inflammatory response in macrophages. We found that Syk interacted with RIP140 in the nuclei and then phosphorylated RIP140 on three conserved tyrosine residues. The Y3F-mutant RIP140 resisted LPS-stimulated degradation, which may have been due to inefficient ubiquitination of RIP140, as phosphorylation of those three tyrosine residues seemed to be independent of the binding of RelA to RIP140 and the association of RIP140 with SOCS1. Published reports have shown that tyrosine phosphorylation of a target protein can promote ubiquitination without affecting the binding of E3 ligase 44, 45 . On the basis of the results presented here, we propose that phosphorylation of the three tyrosine residues may change the conformation of RIP140 and lead to exposure of specific lysine residues to E3 ligase. It remains to be determined which lysine residues on RIP140 are directly involved in ubiquitin conjugation and subsequent degradation.
We have shown that RIP140 degradation contributed to endotoxin tolerance in a gene-specific manner, which suggested that NF-κB interacted with RIP140 to activate only specific genes. We ruled out the possibility of Syk-mediated phosphorylation of RIP140 as a regulator of the interaction of RIP140 with RelA. Because RelA has various post-translational modifications, depending on the stimuli 46 , we postulate that specific modifications of RelA may regulate its interaction with RIP140 and may further determine which genes are specifically regulated by RIP140. Therefore, it would be useful to investigate the regulation of the RelA-RIP140 interaction. RIP140 acts mainly as a corepressor for most transcription factors and nuclear receptors by recruiting histone deacetylase and the carboxy-terminal-binding protein CtBP 47,48 , but it functions as a coactivator for NF-κB by recruiting CBP 26 . It is possible that RIP140 may be modified by RelA-associated kinases or other enzymes after interaction with RelA, which then leads to 'preferential' recruitment of CBP. Studies have suggested that acetylation of histone H3 and H4 is important for the binding of NF-κB to chromatin 46 . It would be useful to investigate if the nondegradable mutant RIP140 can facilitate the binding of RelA in the tolerant state by enhancing the acetyaltion status of histones around the RelA-binding region and how RIP140 may modulate chromatin configuration on genes encoding proinflammatory cytokines. Additional studies are needed to further elucidate the differences among these RIP140 protein complexes; these differences may be part of a previously unknown mechanism for modulating the biological activities of RIP140.
npg It is generally believed that in metabolic tissues, RIP140 antagonizes the action of the coactivator PGC-1 (ref. 14) . A published study has shown that a high-fat diet results in higher RIP140 expression in macrophages, which enhances their proinflammatory potential 27 . PGC-1β can promote the M2 activation of macrophages 32 , and RIP140 is important for the proinflammatory cytokine production characteristic of M1 activation. Here we found that degradation of RIP140 was essential to the establishment of endotoxin tolerance and that lack of degradation of RIP140 attenuated endotoxin tolerance induction in vitro and in vivo. Future studies should evaluate whether the stability or expression of RIP140 is related to sensitivity to septic shock in clinical conditions.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
